Unlocking Q3 Potential of Ares Capital (ARCC): Exploring Wall Street Estimates for Key Metrics

28.10.24 14:16 Uhr

Werte in diesem Artikel
Aktien

20,63 EUR -0,11 EUR -0,51%

The upcoming report from Ares Capital (ARCC) is expected to reveal quarterly earnings of $0.59 per share, indicating no change from the year-ago quarter compared to the year-ago period. Analysts forecast revenues of $766.58 million, representing an increase of 17% year over year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.In light of this perspective, let's dive into the average estimates of certain Ares Capital metrics that are commonly tracked and forecasted by Wall Street analysts.The average prediction of analysts places 'Dividend income' at $141.38 million. The estimate is in contrast to the year-ago figure of $128 million.Analysts' assessment points toward 'Other Income' reaching $15.27 million. The estimate compares to the year-ago value of $12 million.Analysts expect 'Capital Structuring Service Fees' to come in at $44.31 million. The estimate is in contrast to the year-ago figure of $20 million.It is projected by analysts that the 'Interest Income From Investments' will reach $559.50 million. Compared to the present estimate, the company reported $495 million in the same quarter last year.View all Key Company Metrics for Ares Capital here>>>Shares of Ares Capital have demonstrated returns of +3.2% over the past month compared to the Zacks S&P 500 composite's +2% change. With a Zacks Rank #4 (Sell), ARCC is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ares Capital Corporation (ARCC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Ares Capital

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ares Capital

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Ares Capital CorpShs

Analysen zu Ares Capital CorpShs

DatumRatingAnalyst
23.08.2019Ares Capital NeutralCompass Point
19.08.2019Ares Capital OutperformBMO Capital Markets
21.09.2017Ares Capital OutperformOppenheimer & Co. Inc.
28.06.2016Ares Capital NeutralNational Securities
25.02.2016Ares Capital OverweightBarclays Capital
DatumRatingAnalyst
19.08.2019Ares Capital OutperformBMO Capital Markets
21.09.2017Ares Capital OutperformOppenheimer & Co. Inc.
25.02.2016Ares Capital OverweightBarclays Capital
30.09.2015Ares Capital BuyD.A. Davidson & Co.
13.02.2015Ares Capital Market PerformBMO Capital Markets
DatumRatingAnalyst
23.08.2019Ares Capital NeutralCompass Point
28.06.2016Ares Capital NeutralNational Securities
05.05.2015Ares Capital HoldBB&T Capital Markets
20.08.2009Allied Capital market performKeefe, Bruyette & Woods, Inc.
06.02.2007Update Allied Capital Corp.: HoldAG Edwards
DatumRatingAnalyst
06.12.2005Update Allied Capital Corp.: UnderperformHarris Nesbitt

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ares Capital CorpShs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"